Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation. (Q34014380)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18952694%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18952694%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18952694%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Xavier Norel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18952694%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Liliane Louedec

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18952694%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Thierry Cachina

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18952694%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Charles Brink

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18952694%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

24 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18952694%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

published in

Cardiovascular Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18952694%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18952694%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18952694%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

269-277

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18952694%20AND%20SRC:MED&resulttype=core&format=json

Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN287

Differential role of vasoactive prostanoids in porcine and human isolated pulmonary arteries in response to endothelium-dependent relaxants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN287

Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN287

Interleukin-1beta, transforming growth factor-beta1, and bradykinin attenuate cyclic AMP production by human pulmonary artery smooth muscle cells in response to prostacyclin analogues and prostaglandin E2 by cyclooxygenase-2 induction and downregula

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN287

COX-2 and beyond: Approaches to prostaglandin inhibition in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN287

Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN287

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN287

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN287

Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN287

Hypoxic induction of cox-2 regulates proliferation of human pulmonary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN287

TNF-alpha, inefficient by itself, potentiates IL-1beta-induced PGHS-2 expression in human pulmonary microvascular endothelial cells: requirement of NF-kappaB and p38 MAPK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN287

Evidence that a prostanoid produced by cyclo-oxygenase-2 enhances contractile responses of the porcine isolated coronary artery following exposure to lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN287

Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN287

Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN287

Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN287

Cyclo-oxygenase-2 inhibition increases blood pressure in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN287

Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN287

Cyclooxygenase-2 inhibition attenuates lipopolysaccharide-induced cardiovascular failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN287

Prostacyclin release and receptor activation: differential control of human pulmonary venous and arterial tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN287

Interleukin-1beta induces glycosaminoglycan synthesis via the prostaglandin E2 pathway in cultured human cervical fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN287